医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
胞苷酰-(5'->3')-鸟苷 | Phosphoric acid (2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-purin-9-yl)-4-hydroxy-2-hydroxymethyl-tetrahydro-furan-3-yl ester (2R,3S,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl ester | 4785-04-0 | C19H25N8O12P |
|
胞苷-5'-二磷酸三钠 | 34393-59-4 | C9H15N3NaO11P2 |
|
|
胞嘧啶-2,4-13C2,15N3 | Cytosine-2,4-13C2,15N3 | 285978-06-5 | C4H5N3O |
|
胞嘧啶 | Cytosine | 71-30-7 | C4H5N3O |
|
胆酸杂质 | 7,12-dioxolitocholic acid | 517-33-9 | C24H36O5 |
|
胆甾醇硫酸盐 | cholesterol 3-sulfate | 1256-86-6 | C27H46O4S |
|
肌酸乙酯盐酸盐 | creatine ethyl ester hydrochloride | 15366-32-2 | C6H13N3O2*ClH |
|
肉豆蔻醇烟酸酯 | tetradecyl nicotinate | 273203-62-6 | C20H33NO2 |
|
肉桂基哌嗪 | trans-1-cinnamylpiperazine | 87179-40-6 | C13H18N2 |
|
聚二硫二噻唑烷 | bis(4,5-dihydro-1,3-thiazol-2-yl) disulphide | 2801-13-0 | C6H8N2S4 |
|
聚(3-辛基噻吩-2,5-二基),REGIORANDOM,LOWMETALS | Azane;2,5-dimethyl-3-octylthiophene | 104934-51-2 | C14H27NS |
|
聚(3,4-亚乙二氧基噻吩)-聚(苯乙烯磺酸) | 2,3-dihydrothieno[3,4-b][1,4]dioxine;(E)-2-phenylethenesulfonic acid | 155090-83-8 | C14H14O5S2 |
|
联苯戊酮 | 1-([1,1'-biphenyl]-4-yl)pentan-1-one | 42916-73-4 | C17H18O |
|
联苯-4-基(9,9-二苯基芴-2-基)胺 | N-([1,1'-biphenyl]-4-yl)-9,9-diphenyl-9H-fluoren-2-amine | 1268520-04-2 | C37H27N |
|
耐晒黑B盐 | 4,4’-diaminodiphenylamine sulfate | 53760-27-3 | C12H13N3*H2O4S |
|
群勃龙庚酸酯 | Trenbolone Enanthate | 1629618-98-9 | C25H34O3 |
|
羟甲基 EDOT | (2,3-dihydrothieno[3,4-b][1,4]dioxin-3-yl)methanol | 146796-02-3 | C7H8O3S |
|
羟基积雪草甙 | 3,5-Dichloro-3'-thiomorpholinomethyl benzophenone | 898787-90-1 | C18H17Cl2NOS |
|
羟基硫胺素盐酸盐 | oxythiamine chloride hydrochloride | 614-05-1 | C12H16N3O2S*ClH*Cl |
|
羟基喹啉苯甲酸盐 | Oxine benzoate | 7091-57-8 | C16H13NO3 |
|
羟基吡嗪 | pyrazin-2(1H)-one | 6270-63-9 | C4H4N2O |
|
羟基丙烷磺酸吡啶嗡盐 | 1-(2-hydroxy-3-sulfo-propyl)-pyridinium betaine | 3918-73-8 | C8H11NO4S |
|
羟吡酮 | piroctone olamine | 68890-66-4 | C2H7NO*C14H23NO2 |
|
羟吡啶酮 | 1-Hydroxy-2-pyridon | 822-89-9 | C5H5NO2 |
|
羟丙哌嗪 | Dropropizin | 17692-31-8 | C13H20N2O2 |
|
美雄醇 | methylandrostenediol | 521-10-8 | C20H32O2 |
|
美索哒嗪 | mesoridazine | 5588-33-0 | C21H26N2OS2 |
|
美沙拉嗪EP杂质P | 5-amino-2-hydroxy-4'-sulfo-[1,1'-biphenyl]-3-carboxylic acid | 887256-40-8 | C13H11NO6S |
|
美替诺龙庚酸酯 | methenolone enanthate | 303-42-4 | C27H42O3 |
|
美昔得乐 | mexidol | 127464-43-1 | C4H6O4*C8H11NO |
|
美司那 | 2-Mercaptoethanesulfonic acid sodium | 19767-45-4 | C2H6NaO3S2 |
|
美卡比酯 | mecarbinate | 15574-49-9 | C13H15NO3 |
|
美他法仑 | L-m-sarcolysin | 1088-80-8 | C13H18Cl2N2O2 |
|
罗红霉素钙盐(链霉菌属载体) | 10,16-Docosadienoic acid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-, calcium salt (1:1), (4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)- | 56092-82-1 | C41H72CaO9 |
|
罗沙司他N-1 | methyl 2-(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxamido) acetate | 1421312-36-8 | C20H18N2O5 |
|
罗替戈汀中间体 | (S)-(-)-5-hydroxy-2-(n-propylamino)tetralin hydrobromide | 165950-84-5 | BrH*C13H19NO |
|
罗拉吡坦中间体 | benzyl (2S)-2-({(1-R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-phenyl-3,4-dihydropyridine-1(2h)-carboxylate | 552293-34-2 | C30H27F6NO3 |
|
罗拉吡坦中间体 | oxazolidinone | 205654-80-4 | C23H19NO4 |
|
维贝格龙 | vibegron | 1190389-15-1 | C26H28N4O3 |
|
维罗非尼中间体 | N-(3-(5-bromo-1-(2,6-dichlorobenzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | 1262985-24-9 | C24H16BrCl2F2N3O4S |
|
维生素C磷酸酯 | L-ascorbic acid 2-phosphate | 23313-12-4 | C6H9O9P |
|
维洛沙秦 | viloxazine | 46817-91-8 | C13H19NO3 |
|
维拉佐酮中间体5-(哌嗪-1-基)苯并呋喃-2-甲酸乙酯 | ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate | 163521-20-8 | C15H18N2O3 |
|
维喹啉 | [3R,4R]-3-Ethenyl-4-[3-(6-methoxyquinolin-4-yl)propyl]piperidine | 72714-74-0 | C20H26N2O |
|
维兰特罗三苯乙酸盐 | vilanterol trifenatate | 503070-58-4 | C20H16O2*C24H33Cl2NO5 |
|
维兰特罗 | vilanterol | 503068-34-6 | C24H33Cl2NO5 |
|
维他命 K1 2,3-环氧化物 | vitamin K epoxide | 25486-55-9 | C31H46O3 |
|
纽莫康定 B0 | (10S,12R)-N-[(3R,6R,9R,11S,15R,18R,20S,21S,24R,25R)-3-[(1S)-3-amino-1-hydroxy-3-oxopropyl]-6-[(1R,2R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1S)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | 135575-42-7 | C50H80N8O17 |
|
红霉素A肟 | erythromycin A oxime | 13127-18-9 | C37H68N2O13 |
|
紫藤提取物 | 2-amino-3,5-dibromo-6-methylpyridine | 91845-57-7 | C6H6Br2N2 |
|